Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We describe the effect of the proteasome specific inhibitor lactacystin on the metabolic stability of influenza nucleoprotein (NP) and on the generation of antigens presented by human and murine class I molecules of the major histocompatibility complex to cytotoxic T lymphocytes (CTL). We show that cells treated with lactacystin fail to present influenza antigens to influenza-specific CTL, but retain the capacity to present defined epitopes expressed as peptides intracellularly by recombinant vaccinia viruses. This block in antigen presentation can be overcome by expressing the viral protein within the lumen of the endoplasmic reticulum, confirming the specificity of lactacystin for cytosolic proteases. We also show that the effect of lactacystin on antigen presentation correlates with the block of breakdown of a rapidly degraded form of the influenza NP linked to ubiquitin. These results demonstrate that proteasome-dependent degradation plays an important role in the cytosolic generation of CTL epitopes.

Original publication




Journal article


Eur J Immunol

Publication Date





336 - 341


Acetylcysteine, Animals, Antigen-Presenting Cells, Antigens, Viral, Cells, Cultured, Cysteine Endopeptidases, Cysteine Proteinase Inhibitors, Cytosol, Epitopes, H-2 Antigens, Humans, Leupeptins, Mice, Multienzyme Complexes, Nucleocapsid Proteins, Nucleoproteins, Orthomyxoviridae, Peptides, Proteasome Endopeptidase Complex, Signal Transduction, T-Lymphocytes, Cytotoxic, Vaccinia virus, Viral Core Proteins